Ovarian Cancer Clinical Trial

Study of Nutritional Supplement Shakes in People About to Receive Their Debulking Surgery for Ovarian Cancer

Summary

The purpose of this study is to find out if it is possible to establish a nutritional support program for people who are scheduled to receive primary debulking surgery.

Design: This will be a prospective observational study to assess the feasibility of implementing a preoperative nutrition supplementation program.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Age ≥ 18
Scheduled to undergo primary surgical debulking of ovarian, fallopian tube and primary peritoneal cancer
Have a sufficient preoperative window during which the intervention can occur, with the last day of supplementation at least one and no more than two days prior to surgery; scheduling of the procedure should not be delayed due to participation in this investigation

Exclusion Criteria:

Have received neoadjuvant chemotherapy
Debulking surgery scheduled less than 8 days from initial visit
Are scheduled for a minimally invasive procedure
Unable to tolerate oral intake or have gastrointestinal issues that would prevent or prohibit oral supplement consumption
Have diabetes mellitus
Have allergies to the Ensure Surgery Immunonutrition Shake supplement
Have galactosemia

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

23

Study ID:

NCT03956095

Recruitment Status:

Active, not recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 8 Locations for this study

See Locations Near You

Baptist Alliance MCI
Miami Florida, 33143, United States
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Basking Ridge New Jersey, 07920, United States
Memorial Sloan Kettering Monmouth (All Protocol Activities)
Middletown New Jersey, 07748, United States
Memorial Sloan Kettering Bergen (All Protocol Activities)
Montvale New Jersey, 07645, United States
Memorial Sloan Kettering Commack (All Protocol Activities)
Commack New York, 11725, United States
Memorial Sloan Kettering Westchester (All Protocol Activities)
Harrison New York, 10604, United States
Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States
Memorial Sloan Kettering Nassau (All Protocol Activities)
Uniondale New York, 11553, United States

How clear is this clinincal trial information?

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

23

Study ID:

NCT03956095

Recruitment Status:

Active, not recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.